Crym-expressing astrocytes in the striatum have been identified as key regulators of behaviors often seen in neuropsychiatric diseases, opening up new avenues for targeted therapies.
Merck pens pact with Pearl Bio for new biologics in cancer
Merck is teaming up with a Khosla Ventures-backed biotech in a package that could be worth as much as $1 billion to create new biologics